Abstract
In 2006, the Agency for Toxic Substances and Disease Registry received a request to determine whether a cluster of polycythemia vera patients existed in a northeast Pennsylvania community. A significant cluster of PV cases was identified at the nexus of three counties near several hazardous waste sites. The current study evaluated the potential for a select number of environmental contaminants previously detected in the cluster area to induce DNA damage using in vitro assays with hematopoietic stem-cell derived progenitor cells.
CD34+ cells were isolated from normal cord blood samples and were cultured for 48–72 hours to generate erythroid progenitor cells. Eighteen compounds were chosen for the assay; arsenic trioxide, benzo(a)pyrene, benzene, methylene chloride, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), trichloroethylene, potassium chloride, ethylbenzene, benzo[k]fluoranthene, styrene, cadmium chloride, hydroquinone, 1,1,1-trichloroethane, sodium cyanide, manganese chloride, chromium oxide, lead oxide, and sodium arsenite. Genotoxicity of the compounds was determined using the comet assay, and toxicity determined via the cell viability assay.
Using the comet assay, 16 compounds at 10 nM concentration, induced a significant amount of DNA damage compared to the control. When evaluating whether a dose-dependent relationship was present, seventeen of the eighteen compounds led to greater DNA damage with increasing exposure concentrations. 2,3,7,8-TCDD was particularly potent, inducing DNA damage in virtually all cells at 1 μM. In conclusion, most of the toxins evaluated using the comet assay showed potential to induce DNA damage in hematopoietic cells, and the genotoxic effects were dose-dependent.
Keywords: Myeloproliferative neoplasms, Polycythemia vera, Comet assay, In vitro assays
Introduction
In 2005, the Pennsylvania Department of Health requested the assistance of the Agency for Toxic Substances and Disease Registry (ATSDR) in studying the pattern of polycythemia vera (PV) in an area in northeast Pennsylvania, referred to as the tri-county area. The request came after local physicians and community members raised concerns regarding the diagnosis of 4 cases of PV on a rural road in the tri-county area. Concerns also included possible historical and current exposure from a nearby National Priorities List (NPL) site, one of seven in the tri-county area.
PV is a myeloproliferative neoplasm (MPN) of the bone marrow characterized by erythrocytosis [1,2]. MPNs also include essential thrombocytosis (ET) and primary myelofibrosis (PMF). In 2005, researchers identified a somatic mutation, JAK2V617F, found in approximately 97% of PV cases [3]. The etiology of both the mutation and disease remains unknown. Using the JAK2V617F mutation test, ATSDR confirmed 33 PV cases in the tri-county area and identified a statistically significant cluster at the nexus of the three counties [2]. As a result of the initial investigation, ATSDR established a multi partner research portfolio to continue the PV investigation. The purpose of the current study was to evaluate the potential for contaminants known to be present historically within the tri-county area to cause DNA damage using in vitro assays.
Methods
Low density mononuclear cells (MNC) were isolated from normal cord blood collections and erythroid progenitor cells were cultured from isolated CD34+ cells. Eighteen compounds were chosen based on their historical presence in the tri-county area: arsenic trioxide, benzene, benzo(a)pyrene, benzo[k]fluoranthene, cadmium chloride, chromium oxide, ethylbenzene, lead oxide, hydroquinone, manganese chloride, methylene chloride, potassium chloride, sodium arsenite, sodium cyanide, styrene, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), trichloroethylene (TCE), and 1,1,1-trichloroethane. The compounds were evaluated using a cell viability assay and Comet assay at varying concentrations (10 nM, 100 nM, and 1000 nM). Statistical analyses were performed using SAS 9.3 (SAS Institute Inc., Cary, NC). Proc GLM and SNK tests were used to determine increases in DNA damage; statistical significance was set at 0.025 to avoid Type 1 error.
Comet assay
The Cell Biolabs OxiSelect™ Comet Assay kit (Cell bioLabs, Inc) was used. After treatment with each individual compound for 24 hours, cells were mixed with molten agarose before application to the OxiSelect™ Comet Slide. Embedded cells were treated with a lysis buffer and alkaline solution. Samples were electrophoresed in a horizontal chamber to separate intact DNA from damaged fragments and the assay repeated in triplicate for each dose. Following electrophoresis, samples were dried, stained with a DNA dye, and visualized. Fluorescent images were acquired using a IX71 fluorescence microscope and MicroSuite software.
Cell viability assay
In order to verify the effects of toxic compounds on cell viability, erythroid progenitor cells were incubated with each compound at 10, 100, 1000 nM. Briefly, 1 × 105 cells/well were seeded into each well of a 24-well plate, and cultured with IMDM containing 10% of FBS, 50% of SCF and 2 U of EPO, to which each individual compound was added and incubated for 4 days. Cell viability was determined using a 0.4% trypan blue solution. The assay was performed in triplicate for each chemical at each dose.
Results and Discussion
All chemicals were evaluated at the three different concentrations, 10 nM, 100 nM, 1000 nM using the Comet assay. Previous research has shown the comet assay is a well-established sensitive method for detecting genotoxicity in mammalian cells [4–6]. Statistical significance was set at p-value=0.01 to adjust for multiple comparisons. At the 10 nM concentration, arsenic trioxide, benzo(a)pyrene, potassium chloride, benzo(k)fluoranthene, styrene, cadmium chloride, 1,1,1-trichloroethane, TCDD, methylene chloride, sodium cyanide, benzene, chromium oxide, lead oxide, and sodium arsenite generated significantly greater numbers of cells with comets than the control. At 100 nM, benzo(a)pyrene, potassium chloride, benzo(k)fluoranthene, styrene, hydroquinone, 1,1,1-trichloroethane, TCDD, TCE, sodium cyanide, manganese chloride, and chromium oxide were significantly different from the control. At the highest concentration (1,000 nM), arsenic trioxide, benzo(a)pyrene, potassium chloride, styrene, cadmium chloride, hydroquinone, 1,1,1-trichloroethane, TCDD, TCE, methylene chloride, sodium cyanide, benzene, chromium oxide, lead oxide, and sodium arsenite were significantly different from the control. Chromium oxide, sodium cyanide, TCDD, 1,1,1-trichloroethane, styrene, potassium chloride, and benzo(a)pyrene were significantly different from the control at all concentrations. A dose-dependent relationship for benzo(a)pyrene, potassium chloride, styrene, cadmium chloride, hydroquinone, TCDD, TCE, methylene chloride, benzene, lead oxide, and sodium arsenite and DNA damage was found. Similarly, studies using the comet assay have shown many of these contaminants can induce DNA damage including arsenic trioxide, benzene, lead, cadmium, ethylbenzene, TCE, and styrene [7–11]. However, the literature is sparse on any associations between chemicals exposures and PV. An in-depth review by Anderson et al. cited two studies that show an increased risk of MPNs including PV in persons exposed to benzene or petroleum [12–14].
Concerning the cell viability assay, seventeen compounds resulted in significantly decreased cell viability in a dose-dependent manner (Table 1). For benzene, cadmium chloride, chromium oxide, potassium chloride, lead oxide, and sodium cyanide, cell viability was significantly decreased at increasing concentrations. Using the Comet assay and the cell viability assay, treatment with 1,000 nM TCDD resulted in 100% cell death and 100% of cells having DNA damage.
Table 1:
Percent of non-viable cells with standard deviation after treatment with the environmental contaminants as shown by the cell viability assay.
Percent of non-viable cells (%) | |||
---|---|---|---|
Chemical | 10 nM (SD) | 100 nM (SD) | 1000 nM (SD) |
Arsenic trioxide* | 5.00 (7.00) | 32.33 (11.37) | 54.33 (6.03) |
Benzo(a)pyrene* | 1.00 (1.73) | 42.67 (13.28) | 64.00 (8.72) |
Potassium chloride* | 0.00 (0.00) | 42.00 (12.12) | 79.67 (1.53) |
Ethylbenzene* | 0.00 (0.00) | 38.00 (7.21) | 10.00 (10.00) |
Benzo[k]fluoranthene* | 2.67 (4.61) | 38.00 (16.37) | 59.00 (8.66) |
Styrene* | 14.33 (15.31) | 51.00 (9.17) | 55.33 (3.21) |
Cadmium chloride* | 2.67 (4.62) | 42.33 (7.37) | 86.33 (0.58) |
Hydroquinone* | 1.00 (1.00) | 50.67 (5.77) | 51.00 (9.00) |
1,1,1-Trichloroethane* | 7.00 (5.57) | 46.00 (6.24) | 61.00 (3.46) |
TCDD* | 13.33 (14.47) | 44.33 (11.93) | 100.00 (0.00) |
TCE | 9.00 (7.94) | 27.33 (11.93) | 38.33 (4.51) |
Methylene chloride* | 0.00 (0.00) | 32.33 (19.76) | 45.00 (1.00) |
Sodium cyanide* | 0.00 (0.00) | 36.33 (8.02) | 55.00 (2.00) |
Manganese chloride | 3.33 (4.16) | 41.00 (3.61) | 36.33 (2.08) |
Benzene* | 9.00 (7.81) | 29.33 (2.31) | 48.33 (1.15) |
Chromium oxide* | 1.33 (2.31) | 25.00 (5.00) | 44.00 (2.65) |
Lead oxide* | 3.33 (4.16) | 31.67 (1.15) | 51.00 (9.00) |
Sodium arsenite* | 20.67 (15.31) | 23.67 (2.08) | 65.00 (5.57) |
The percent of non-viable cells significantly increased as the dose increased.
Using the Comet assay, the majority of the contaminants induced DNA damage. Similarly, cell viability decreased after treatment with a contaminant at concentrations of 100 nM and 1000 nm for all except TCE. For both the Comet assay and cell viability assay, the genotoxic effects of the compounds were dose-dependent. Interestingly, 2,3,7,8-TCDD was particularly toxic, inducing DNA damage and cell death in virtually all cells at a concentration of 1,000 nM.
To determine comparability of chemical concentrations in the current study and historical environmental contamination, we used information from the ATSDR PV environmental database to determine maximum historical groundwater concentrations in the tri-county area. Most of the chemicals had historical groundwater concentrations lower than concentrations used in the assays. For example, 1000 nM of styrene is approximately 104.14 μg/L which is 9.5 times greater than the historically present 11 μg/L. Similarly, 1000 nM of benzo(a)pyrene is approximately 252.31 μg/l, much larger than the historically present 4 μg/L in groundwater. However a few chemicals had higher concentrations in the tri-county area, including benzene with a maximum concentration of 3430 μg/L compared to the 1000 nM (78.1 g/mol) concentration used in the assay.
The present study does have limitations. Specifically, the concentrations used in the current study might not be indicative of actual historical exposure levels to residents in the tri-county area. Additionally, extrapolating doses from in vitro testing to environmental exposure is fraught with uncertainties. While the present study indicates that some of the chemicals historically present do have genotoxic effects, we could not determine whether the genotoxic effects played a role in the creation of the cluster of PV patients. Future research could involve calculating target levels (mononuclear intracellular levels) using recent advances in PBPK modeling to help elucidate these findings.
Acknowledgements
The findings and conclusions in this report are those of the authors and do not necessarily represent the official views or positions of the Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry or the Department of Health and Human Services.
Abbreviations:
- ATSDR
Agency for Toxic Substances and Disease Registry
- MPN
Myeloproliferative Neoplasm
- PV
Polycythemia Vera
- ET
Essential Thrombocytosis
- PMF
Primary Myelofibrosis
- TCDD
3,7,8-tetrachlorodibenzo-p-dioxin
- TCE
Trichloroethylene
- NPL
National Priorities List
- MNC
Mononuclear Cells
References
- 1.Seaman V, Jumaan A, Yanni E, Lewis B, Neyer J, et al. (2009) Use of molecular testing to identify a cluster of patients with polycythemia vera in eastern Pennsylvania. Cancer Epidemiol Biomarkers Prev 18: 534–539. [DOI] [PubMed] [Google Scholar]
- 2.Seaman V, Dearwent S, Gable D, Lewis B, Metcalf S, et al. (2010) A multi-disciplinary investigation of a polycythemia vera cancer cluster of unknown origin. Int J Environ Res Public Health 7: 1139–1152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Kralovics R, Passamonti F, Buser AS, Teo S, Tiedt R, et al. (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352: 1779–1790. [DOI] [PubMed] [Google Scholar]
- 4.Collins AR (2004) The comet assay for DNA damage and repair; Principles, applications, and limitations. Mol Biotechnol 26: 249–261. [DOI] [PubMed] [Google Scholar]
- 5.Fairbairn DW, Olive PL, O’Neill KL (1995) The comet assay: a comprehensive review. Mutat Res 339: 37–59. [DOI] [PubMed] [Google Scholar]
- 6.Singh N, McCoy M, Tice R, Schneider E (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175: 184–191. [DOI] [PubMed] [Google Scholar]
- 7.Robbiano L, Baroni D, Carrozzino R, Mereto E, Brambilla G (2004) DNA damage and micronuclei induced in rat and human kidney cells by six chemicals carcinogenic to the rat kidney. Toxicology 204: 187–195. [DOI] [PubMed] [Google Scholar]
- 8.Stevens J, Graham B, Walker A, Tchounwou P, Rogers C (2010) The Effects of Arsenic Trioxide on DNA Synthesis and Genotoxicity in Human Colon Cancer Cells. Int J Environ Res Public Health 7: 2018–2032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Teixeira J, Gaspar J, Coelho P, Costa C, Pinho-Silva S, et al. (2010) Cytogenetic and DNA damage on workers exposed to styrene. Mutagenesis 25: 617–621. [DOI] [PubMed] [Google Scholar]
- 10.Ustündağ A, Behm C, Föllmann W, Duydu Y, Degen G (2014) Protective effect of boric acid on lead- and cadmium-induced genotoxicity in V79 cells. Arch Toxicol 88: 1281–1289. [DOI] [PubMed] [Google Scholar]
- 11.Chen CS, Hseu YC, Liang SH, Kuo JY, Chen SC (2008) Assessment of genotoxicity of methyl-tert-butyl ether, benzene, toluene, ethylbenzene, and xylene to human lymphocytes using comet assay. Journal of Hazardous Materials 153: 351–356. [DOI] [PubMed] [Google Scholar]
- 12.Anderson L, Duncombe A, Hughes M, Mills M, Wilson J, et al. (2012) Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasms. Am J Hematol 87: 175–182. [DOI] [PubMed] [Google Scholar]
- 13.Quiroga Micheo E, Calcagno EJ, Calabria SI (1981) Retrospective epidemiological study of hemopoietic system neoplasms in Argentina. Medicina 41: 187–200. [PubMed] [Google Scholar]
- 14.Terreros MC, Apezteguia M, Slavutsky IR, Guimarey LM (1997) Exposure to occupational and environmental risk factors in hematologic disorders. Neoplasia 14: 133–136. [Google Scholar]